Monitor housing starts data and raw material cost trends for near-term headwind persistence. The CE Mark for MediTrac opens a European medical gas tubing market, but revenue contribution is likely years away — watch for initial commercial traction and any partnership announcements. The new TracPipe fitting launch may stabilize volumes in H2 2026 if construction activity recovers.
Price Chart
Executive Summary
Omega Flex reported Q2 2026 earnings with net sales of $24.1M (down 5.8% YoY) and EPS of $0.27 (down 34.1% YoY), driven by lower housing starts, higher raw material costs, and tariffs. The company also announced CE Mark approval for its MediTrac corrugated medical tubing, a potential new growth platform. The combination of declining core financials and a promising but early-stage regulatory milestone produces a mixed outlook.
Key Financial Metrics
Key Facts
- Q2 2026 net sales of $24.1M, down 5.8% YoY from $25.5M
- Q2 2026 EPS of $0.27, down 34.1% YoY from $0.41
- Net income for Q2 2026 was $2.7M, down 35.6% YoY
- Six-month net sales $47.2M, down 3.5% YoY; net income $4.8M, down 38.5% YoY
- Declines attributed to lower housing starts, higher raw material costs, tariffs, and marketing spend for new re-engineered gas piping fitting
- CE Mark certification received for MediTrac corrugated medical tubing under EU MDR 2017/745 as a Class IIa device
- New TracPipe System branded fitting introduced on July 1, 2026, targeting residential and commercial markets
- Company states higher costs from inventory procurement and marketing for new fitting are expected to be limited in duration
Financial Impact
Q2 2026 net sales declined $1.5M (5.8%) YoY; net income declined $1.5M (35.6%) YoY; EPS declined $0.14 (34.1%) YoY
Risk Factors
- Continued decline in housing starts suppressing core gas piping volumes
- Raw material cost inflation and tariff impacts persisting beyond management's expected normalization period
- MediTrac CE Mark is a regulatory milestone, not a revenue event — commercial adoption timeline is uncertain
- New fitting marketing and inventory procurement costs may continue to pressure margins in the near term
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-037334 |
| Exhibit: ex99-1.htm | 0001493152-26-037334 |
| Document: 0001493152-26-037334-index-headers.html | 0001493152-26-037334 |
| Document: 0001493152-26-037334-index.html | 0001493152-26-037334 |
| Document: 0001493152-26-037334.txt | 0001493152-26-037334 |
| 8-K Data (Synthetic) | 0001493152-26-037334 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 18, 2026 5w ago | Press Release | $25.41 | awaiting T+60 | — | $24.29 (−4.40%) |
Aug 12, 2026 10w ago | Press Release | $28.81 | awaiting T+60 | — | $24.29 (−15.69%) |
Aug 12, 2026 10w ago | 8-K | $28.81 | awaiting T+60 | — | $24.29 (−15.69%) |
Jun 15, 2026 19w ago | 8-K | $30.96 | awaiting T+60 | — | $24.29 (−21.54%) |
Apr 28, 2026 25w ago | DEFA14A | $34.21 $29.45 | ▼ −13.91% | ▼ −17.90% | $24.29 (−29.00%) |
Mar 25, 2026 30w ago | Press Release | $29.74 $30.32 | ▲ +1.93% | ▼ −12.02% | $24.29 (−18.34%) |
Mar 4, 2026 33w ago | 8-K | $30.40 $29.90 | ▲ +1.64% | ▲ +12.94% | $24.29 (+20.09%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers